Nrx pharmaceuticals, inc. announces pricing of $2.0 million underwritten public offering of common stock

Radnor, pa. , april 18, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp), ("nrx pharmaceuticals" or the "company"), a clinical-stage biopharmaceutical company, today announced the pricing of its underwritten public offering of shares of its common stock at a public offering price of $3.30 per share, for aggregate gross proceeds of approximately $2.0 million, prior to deducting underwriting discounts and other offering expenses.
NRXP Ratings Summary
NRXP Quant Ranking